MICHAEL P. TARNOK - Corporate Board Profile

DYADIC INTERNATIONAL INC

Filing Date	Source Excerpt
2019-04-30	Michael P. Tarnok, 64, joined Dyadic’s board of directors on June 12, 2014 and has served on the Company’s audit, nominating and compensation committees, and on January 12, 2015 Mr. Tarnok was appointed Dyadic’s Chairman of the Board of Directors. Mr. Tarnok is also currently a board member of Global Health Council, and Ionetix, Inc. In addition, Mr. Tarnok’s prior board service includes Keryx Biopharmaceuticals, Inc., where he also served as Chairman of the Board. Mr. Tarnok is a seasoned finance and operational executive with extensive pharmaceutical industry experience in a wide range of functional areas. He spent the majority of his career at Pfizer Inc., which he joined in 1989 as Finance Director-US Manufacturing and from 2000 to 2007 served as a Senior Vice President in Pfizer’s US Pharmaceutical Division. In this position, Mr. Tarnok managed multiple responsibilities for the division including, finance, access contracting, trade management, information technology, Sarbanes-Oxley compliance and the Greenstone generics division. Prior to joining Pfizer, Mr. Tarnok worked primarily in financial disciplines for ITT Rayonier, Inc., Celanese Corporation and Olivetti Corporation of America. Mr. Tarnok earned an M.B.A. in Marketing from New York University and a B.S. in Accounting from St. John’s University.
2020-05-13	Mr. Tarnok earned an M.B.A. in Marketing from New York University and a B.S. in Accounting from St. John’s University.
2021-04-27	Mr. Tarnok is a seasoned finance and operational executive with extensive pharmaceutical industry experience. He managed multiple responsibilities including finance, access contracting, trade management, information technology, Sarbanes-Oxley compliance, and the Greenstone generics division.
2022-04-26	Mr. Tarnok is a seasoned finance and operational executive with extensive pharmaceutical industry experience in a wide range of functional areas. He spent most of his career at Pfizer Inc., which he joined in 1989 as Finance Director-US Manufacturing and from 2000 to 2007 served as a Senior Vice President in Pfizer’s US Pharmaceutical Division. In this position, Mr. Tarnok managed multiple responsibilities for the division including, finance, access contracting, trade management, information technology, Sarbanes-Oxley compliance, and the Greenstone generics division. Prior to joining Pfizer, Mr. Tarnok worked primarily in financial disciplines for ITT Rayonier, Inc., Celanese Corporation and Olivetti Corporation of America. Mr. Tarnok earned an M.B.A. in Marketing from New York University and a B.S. in Accounting from St. John’s University.
2023-04-27	Mr. Tarnok managed finance, access contracting, trade management, information technology, Sarbanes-Oxley compliance at Pfizer, and earned an M.B.A. and B.S. in Accounting.
2024-04-24	Mr. Tarnok is a seasoned finance and operational executive with extensive pharmaceutical industry experience. He spent most of his career at Pfizer Inc., managing finance, access contracting, trade management, information technology, Sarbanes-Oxley compliance, and the Greenstone generics division.

Data sourced from SEC filings. Last updated: 2026-02-03